Quest Diagnostics
DGX
#1119
Rank
โ‚น2.023 T
Marketcap
โ‚น18,281
Share price
-0.79%
Change (1 day)
22.52%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2025 (TTM): โ‚น115.26 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are โ‚น11.03 Billion. , an increase over its 2024 earnings that were of โ‚น111.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น125.05 B12.17%
2024 โ‚น111.48 B3.98%
2023 โ‚น107.21 B-8.5%
2022 โ‚น117.17 B-52.48%
2021 โ‚น246.59 B37.95%
2020 โ‚น178.75 B75.09%
2019 โ‚น102.09 B16.2%
2018 โ‚น87.85 B-10.1%
2017 โ‚น97.72 B-5.16%
2016 โ‚น103.03 B-1.54%
2015 โ‚น104.65 B31%
2014 โ‚น79.88 B-37.52%
2013 โ‚น127.86 B26.93%
2012 โ‚น100.74 B24.01%
2011 โ‚น81.23 B-27.7%
2010 โ‚น112.36 B-3.55%
2009 โ‚น116.50 B19.59%
2008 โ‚น97.42 B12.54%
2007 โ‚น86.56 B-11.7%
2006 โ‚น98.03 B13.49%
2005 โ‚น86.38 B9.02%
2004 โ‚น79.23 B13.19%
2003 โ‚น70.00 B36.03%
2002 โ‚น51.46 B63.07%
2001 โ‚น31.55 B65.49%
2000 โ‚น19.06 B1297.84%
1999 โ‚น1.36 B-73.37%
1998 โ‚น5.12 B-384.21%
1997 -โ‚น1.81 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
LabCorp
LH
โ‚น126.34 B 1.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.95 B-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น0.19 Billion-100.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น10.11 Billion-108.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น51.34 B-58.94%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น0.75 Billion-100.59%๐Ÿ‡บ๐Ÿ‡ธ USA